Ascend Wellness Holdings (AAWH) Amortization of Deferred Charges (2020 - 2026)

Ascend Wellness Holdings' (AAWH) quarterly Amortization of Deferred Charges came in at $765000.0 in Q1 2026, up 8.05% year-on-year from $708000.0 in Q1 2025, and up 49.41% quarter-over-quarter from $512000.0 in Q4 2025.

Ascend Wellness Holdings (AAWH) Amortization of Deferred Charges (2020 - 2026) Analysis & Trends

Ascend Wellness Holdings' Amortization of Deferred Charges history runs 7 years deep, the most recent figure standing at $765000.0 for Q1 2026.

  • On a quarterly basis, Amortization of Deferred Charges rose 8.05% year-over-year to $765000.0 in Q1 2026; TTM through Mar 2026 was $2.1 million, a 4.5% decrease from a year earlier, with the FY2025 full-year figure at $2.1 million, up 5.09% from the prior year.
  • Amortization of Deferred Charges rose to $765000.0 in Q1 2026 per AAWH's latest filing, from $512000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $765000.0 in Q1 2026 and bottomed at $122000.0 in Q4 2022.
  • The 5-year median for Amortization of Deferred Charges is $451000.0 (2024), against an average of $410823.5.
  • Across the five-year window, Amortization of Deferred Charges slumped 62.46% in 2022 and surged 127.43% in 2024, its largest moves.
  • Year by year, Amortization of Deferred Charges stood at $122000.0 in 2022, then soared by 85.25% to $226000.0 in 2023, then jumped by 127.43% to $514000.0 in 2024, then retreated by 0.39% to $512000.0 in 2025, then surged by 49.41% to $765000.0 in 2026.
  • Per Business Quant, the three latest AAWH Amortization of Deferred Charges figures stand at $765000.0 (Q1 2026), $512000.0 (Q4 2025), and $359000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.28 Bn 87.42 Bn -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn
10 Ascend Wellness Holdings 78.95 Mn 18.03 Mn 44.88 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 765,000.00
Mar 31, 2026 765,000.00
Dec 31, 2025 512,000.00
Dec 31, 2025 512,000.00
Sep 30, 2025 359,000.00
Sep 30, 2025 359,000.00
Jun 30, 2025 486,000.00
Jun 30, 2025 486,000.00
Mar 31, 2025 708,000.00
Mar 31, 2025 708,000.00
Dec 31, 2024 514,000.00
Dec 31, 2024 514,000.00
Sep 30, 2024 486,000.00
Sep 30, 2024 486,000.00
Jun 30, 2024 514,000.00
Jun 30, 2024 514,000.00
Mar 31, 2024 451,000.00
Mar 31, 2024 451,000.00
Dec 31, 2023 226,000.00
Dec 31, 2023 226,000.00